Controversy over domestic drugmaker Medigen’s COVID-19 vaccine could have been avoided had the company published data on its phase 2 clinical trials in international journals, National Taiwan University (NTU) College of Public Health vice dean Tony Chen (陳秀熙) said yesterday.
The government on Sunday granted emergency use authorization (EUA) to the Medigen jab after an expert panel said that antibody levels in the blood of phase 2 trial participants met local standards.
However, critics said that the experts’ reasoning was not convincing because not all trial data had been publicized and that Taiwan is the only country to conditionally approve a vaccine that has not yet passed phase 3 clinical trials.
Medigen on Tuesday said it had received approval to conduct phase 3 trials on 1,000 people in Paraguay.
Chen yesterday said that the Paraguay trials’ methodology and safety precautions would be well within international standards, but whether the vaccine could provide sufficient protection, especially against highly infectious variants of SARS-CoV-2, could only be determined with additional trials.
Chen said that he believes the expert panels’ assessment on which the EUA is based, but that the company lacks sufficient credibility based on publication in scientific journals.
“Trial data of the COVID-19 vaccines that are in use worldwide — AstraZeneca, Pfizer-BioNTech, Moderna, Johnsons & Johnson and Novavax, among others — have been published in credible international journals,” Chen said, adding that this, not the transparency of the approval process in various countries, gives them credibility.
Even China last year publicized the phase 2 trial results of the Sinovac COVID-19 vaccine, he said.
The publication of trial data is a critical step that the Medigen vaccine must take, Chen said, adding that verification by the international medical community would be crucial to calm the worries of Taiwanese.
Taoyuan Mayor Cheng Wen-tsan (鄭文燦) and Tainan Mayor Huang Wei-che (黃偉哲), both of the Democratic Progressive Party, have said that they would be willing to receive the Medigen vaccine as their second shot, while New Taipei City Mayor Hou You-yi (侯友宜) of the Chinese Nationalist Party (KMT) has said that the jab’s efficacy should first be determined by the scientific community, not by politics.
Transparency is key to winning public support, Hou said, adding that public support is key to whether the Medigen jab would become widely accepted.
Additional reporting by Lai Hsiao-tung
The heads of three major US banks on Wednesday pledged that they would withdraw from the Chinese market if Washington imposed sanctions on Beijing in response to an invasion of Taiwan. JP Morgan Chase chairman and CEO Jamie Dimon, Bank of America chairman and CEO Brian Moynihan and Citigroup CEO Jane Fraser told lawmakers at a hearing of the US House of Representatives Committee on Financial Services in Washington that the three banks would follow the guidance of the US government to exit China if necessary. The three bankers made the pledge after US Representative Blaine Luetkemeyer asked the three if they
HELPING Hand: The government is to provide NT$30,000 in disaster relief to displaced people, while those who have been severely injured would receive NT$250,000 Contingency bus services are transporting rail passengers between Hualien and Taitung counties on the nation’s east coast after a magnitude 6.8 earthquake damaged facilities on Sunday, the Taiwan Railways Administration (TRA) said yesterday. Until normal train services resume, the bus services would be provided every hour from 6am to 8pm between Hualien and Taitung railway stations, with stops in Jian (吉安), Shoufong (壽豐), Fonglin (鳳林), Guangfu (光復), Ruisuei (瑞穗), Yuli (玉里), Fuli (富里), Chihshang (池上), Guanshan (關山) and Luye (鹿野), the TRA said. While most of the damaged railway tracks would be repaired by today and others by Sunday, Minister of Transportation
CASELOADS FALLING: The nation’s latest COVID-19 wave seems to have peaked sooner than expected and the CECC has drawn up plans to reopen the border Changes in daily COVID-19 caseloads over the next couple of weeks would affect the timing of the border being reopened, the Central Epidemic Command Center (CECC) said yesterday as it reported 46,673 new local and 229 imported cases, as well as 39 deaths. The CECC had previously predicted that a wave of infections fueled by the Omicron BA.5 subvariant of SARS-CoV-2 would peak yesterday. Yesterday’s caseload was 6 percent lower than Wednesday last week and the decline was evident across the nation, said Centers for Disease Control (CDC) Director-General Chou Jih-haw (周志浩), head of the CECC’s disease surveillance division. Deputy Minister of Health
CHINA CRITIC: Prime ministerial candidate Giorgia Meloni, the front-runner in today’s election, said that she would not renew a Belt and Road Initiative deal with Beijing Italian lawmaker Giorgia Meloni, the front-runner to become the country’s next prime minister, is expected to reverse course on Italy’s support for China’s Belt and Road Initiative and strengthen ties with Taiwan if a coalition headed by her party wins the country’s general election today. “Without any doubt, if there is a center-right government, it is sure that Taiwan will be an essential concern for Italy,” Meloni told the Central News Agency in an interview. Italians are to vote in a snap election triggered by the resignation of Italian Prime Minister Mario Draghi following a failed attempt to get his coalition partners